- Home
- SDRL vs ELVN Comparison
SDRL vs ELVN Comparison
Compare SDRL & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDRL | ELVN |
|---|---|---|
| Founded | 2005 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SDRL | ELVN |
|---|---|---|
| Price | $48.08 | $42.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $56.00 | $43.40 |
| AVG Volume (30 Days) | ★ 591.3K | 577.5K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.61 | 3.17 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,437,000,000.00 | N/A |
| Revenue This Year | $5.22 | N/A |
| Revenue Next Year | $16.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.75 | N/A |
| 52 Week Low | $22.87 | $14.79 |
| 52 Week High | $55.47 | $48.53 |
Technical Indicators
Market Signals| Indicator | SDRL | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 54.13 |
| Support Level | $46.78 | $38.58 |
| Resistance Level | $49.61 | $45.14 |
| Average True Range (ATR) | 2.07 | 2.28 |
| MACD | -0.41 | -0.06 |
| Stochastic Oscillator | 12.71 | 61.59 |
Price Performance
Historical ComparisonAbout SDRL Seadrill Limited
Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.